Claims for Patent: 8,772,030

Summary for Patent: 8,772,030

Title:	Cardiac stem cells and methods for isolation of same
Abstract:	Method for the isolation, expansion and preservation of cardiac stem cells from human or animal tissue biopsy samples to be employed in cell transplantation and functional repair of the myocardium or other organs. Cells may also be used in gene therapy for treating cardiomyopathies, for treating ischemic heart diseases and for setting in vitro models to study drugs.
Inventor(s):	Giacomello; Alessandro (Rome, IT), Messina; Elisa (Rome, IT), Battaglia; Massimo (Rome, IT), Frati; Giacomo (Rome, IT)
Assignee:	Universita Degli Studi di Roma \"La Sapienza\" (Rome, IT)
Application Number:	13/245,788
Patent Claims:	1. A method for obtaining cardiospheres from a cardiac tissue biopsy sample, said method comprising the following steps: fragmenting a cardiac tissue biopsy sample to generate a plurality of cardiac tissue fragments; wherein the cardiac tissue biopsy sample is a non-embryonic cardiac tissue obtained from the ventricle, atrium or auricle of a heart; removing non-cardiac tissue or non-cardiac cells from said cardiac tissue fragments by partial enzymatic digestion of said cardiac tissue fragments; discarding said non-cardiac tissue or non-cardiac cells and retaining said partially digested cardiac tissue fragments; culturing said partially digested cardiac tissue fragments until phase-bright cells migrate from said cardiac tissue fragments; collecting said phase-bright cells; culturing said phase-bright cells on a treated surface in a culture media comprising 3.5% serum to generate one or more cardiospheres; wherein the one or more cardiospheres are spheroid structure of about 20 .mu.m to about 150 .mu.m in culture, wherein said cardiospheres are multicellular aggregates comprising stem cells, cardiac cells, and endothelial cells, wherein said stem cells express one or more stem cell markers selected from the group consisting of CD-34, ckit, and sca-1 within 12 hours of said cardiospheres being generated, wherein said endothelial cells express one or more endothelial markers selected from the group consisting of KDR, flk-1 and CD31 within 12 hours of said cardiospheres being generated; and harvesting said one or more cardiospheres, thereby obtaining cardiospheres. 2. The method of claim 1, wherein said removing further comprises dissection of said cardiac tissue biopsy sample. 3. The method of claim 1, wherein said partial enzymatic digestion is performed using trypsin, collagenase, or combinations thereof. 4. The method of claim 1, wherein said culture media comprises one or more of epidermal growth factor (EGF), fibroblast growth factor (FGF), cardiotropin-1, and thrombin. 5. The method of claim 1, further comprising disaggregating said harvested cardiospheres to generate disaggregated cells and culturing said disaggregated cells in said culture media to generate additional cardiospheres. 6. The method of claim 5, wherein said disaggregated cells are cultured on said treated growth surface. 7. The method of claim 1, wherein said treated growth surface comprises polylysine. 8. The method of claim 1, wherein said culture media comprises a serum substitute. 9. The method of claim 8, wherein said serum substitute comprises B27. 10. The method of claim 1, wherein said culture media is horse serum free. 11. The method of claim 10, wherein said culture media further comprises growth factors.

Details for Patent 8,772,030

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2023-07-31